CD8A and neoplasm: The prominent immunotherapeutic strategies described above all focus on generating robust tumor-directed T cell responses, which is crucial to inducing effective and long-lasting anti-tumor immunity, as there is a strong correlation between tumor-infiltrating CD8+ T cells and patient survival in virtually all cancer types (9).